About Breastcon

It is a great honor and privilege to serve as Patron of Breast-Con’ 25. Academic forums of this kind provide an invaluable opportunity to exchange knowledge, share clinical experience, and explore innovations in breast cancer care. I commend the organizers for their vision for creating this platform, which has already demonstrated its impact through the remarkable success of last year’s conference. Building upon that achievement, Breast-Con’ 25 will undoubtedly strengthen collaboration, inspire research, and further advance patient-centered care. I look forward to fruitful discussions and wish the conference every success.

Breast-Con’ 25 is not just a scientific meeting; it is a reflection of our collective vision to redefine how breast cancer is understood and treated in our region. By bringing together experts from diverse disciplines, this forum emphasizes that excellence in care emerges from dialogue, teamwork, and shared responsibility. Every session planned this year has been designed to spark meaningful discussion, highlight practical solutions, and encourage collaboration across specialties. What makes Breast-Con’ 25 unique is its spirit of inclusivity—welcoming surgeons, oncologists, radiologists, pathologists, and allied professionals to work side by side for a common cause. As Patron, I am proud to support this initiative that builds bridges between knowledge and practice, between research and patient care. I am confident that the ideas born here will extend far beyond this conference hall, influencing daily practice and improving lives. I congratulate the organizers on their tireless efforts and warmly invite all participants to engage wholeheartedly in this academic journey.

It is both an honor and a privilege to welcome you all to Breast-Con’ 25. This year’s conference builds upon a strong tradition of academic excellence and collaboration, bringing together distinguished colleagues from across the spectrum of oncology. Our shared theme, “Bridging Modalities with Precision,” reflects our commitment not only to scientific advancement but also to delivering integrated and compassionate care to our patients. The success of last year’s conference reaffirmed the power of multidisciplinary dialogue in shaping the future of breast cancer management. In 2025, we aspire to take that vision further—by fostering deeper connections, showcasing pioneering research, and creating an environment where ideas evolve into impactful practices. I warmly welcome all the participants, speakers, and collaborators to be part of this journey. Let us make Breast-Con’ 25 not just a conference, but a milestone in our ongoing mission to improve lives through knowledge, precision, and teamwork.

It gives me great pleasure to welcome you to the 2nd Breast Cancer Conference – Breast-Con’ 25, to be held on October 4–5, 2025 at PC Hotel, Karachi. This year’s theme, “Bridging Modalities with Precision”, reflects our collective vision to integrate the latest advancements in surgery, medical oncology, radiation oncology, imaging, and pathology into a truly multidisciplinary platform. Our goal is to create meaningful discussions that translate into better outcomes for patients across Pakistan and beyond. Breast-Con’ 25 will not only highlight innovations in breast cancer management but will also provide an excellent opportunity for young investigators and trainees to showcase the

It gives me great pleasure to welcome you to the Breast-c0n’ 25, being held at PC Hotel, Karachi, on October 4–5, 2025, with the theme: “Bridging Modalities with Precision.” Just like last year, this year’s scientific program has also been carefully designed to bring together experts in surgical, medical, and radiation oncology, along with radiology, pathology, and allied specialties, to address the most pressing and evolving aspects of breast cancer care. Our sessions will highlight precision-based approaches, including genomics-driven decision-making, targeted axillary dissection (TAD), accelerated partial breast irradiation (APBI), systemic therapy strategies for HR+, HER2+, and triple negative disease, as well as reconstruction and survivorship. Special emphasis has been placed on the needs of young breast cancer patients, fertility preservation, and patient-centered supportive care. We are also excited to host a Young Investigator Session, providing a platform for residents and young fellows to present their research and contribute to the future of oncology in Pakistan. On behalf of the scientific committee, I warmly invite you to join us for two days of knowledge exchange, collaboration, and innovation, as we work together towards advancing breast cancer care in our region.